Neurological complications of Herpes zoster;Le zona et ses complications neurologiques

Revue Neurologique

Volumn 162, Issue 8-9, 2006, Pages 879-887

  Mathis, S ^a   Gil, R ^a   Neau, J P ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Herpes zoster; Neurological manifestations; Treatment

Indexed keywords

ACICLOVIR; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIVIRUS AGENT; CARBAMAZEPINE; CHLORDIAZEPOXIDE; CORTICOSTEROID; FAMCICLOVIR; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; OXCARBAZEPINE; PREDNISONE; TOPIRAMATE; VALACICLOVIR; VALPROIC ACID; VARICELLA ZOSTER VACCINE;

ARTERITIS; ASEPTIC MENINGITIS; BRAIN DISEASE; DRUG EFFICACY; GUILLAIN BARRE SYNDROME; HERPES ZOSTER; HERPES ZOSTER OTICUS; HUMAN; IMMUNOCOMPETENCE; MYELITIS; NEURITIS; NEUROLOGIC DISEASE; NEUROLOGICAL COMPLICATION; OPTIC NEURITIS; OUTCOME ASSESSMENT; PERIPHERAL NERVOUS SYSTEM; REVIEW; REYE SYNDROME; RISK ASSESSMENT; SYMPTOMATOLOGY; TREATMENT OUTCOME; VASCULITIS;

EID: 33748503901     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(06)75096-2     Document Type: Article

References (96)

1. AKIYAMA N. (2000). Herpes zoster infection complicated by motor paralysis. J Dermatol, 27: 252-257.
2. th edition, Edited by Walton J. Oxford university Press, Oxford. pp. 317-350.
3. ARGOFF CE, KATZ N, BACKONJA M. (2004). Treatment of postherpetic neuralgia: a review of therapeutic options. J Pain Symptom Manage, 28: 396-411.
4. BALFOUR HH. (1999). Antiviral drugs. N Engl J Med, 340: 1255-1268.
5. BENNETTO L, SCOLDING N. (2004). Inflammatory/post-infectious encephalomyelitis. J Neurol Neurosurg Psychiatry, 75 (suppl I): i22-i28.
6. BEUTNER KR, FRIEDMAN DJ, FORSZPANIAK C, ANDERSEN PL, WOOD MJ. (1995). Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother, 39: 1546-1553.
7. BUCHBINDER SP, KATZ MH, HESSOL NA et al. (1992). Herpes zoster and human immunodeficeincy virus infection. J Infect Dis, 166: 1153-1156.
8. CABEZÓN RUIZ S, CISNEROS JM, LAGE GALLE E et al. (2003). Characteristics and repercussion of Varicella-zoster virus infection in cardiac transplant. Transplant Proc, 35: 2004-2005.
9. CARROLL WM, MASTAGLIA FL. (1979). Optic neuropathy and ophthalmoplegia in herpes zoster oticus. Neurology, 29: 726-729.
10. CHAN J, BERGSTROM RT, LANZA DC, OAS JG. (2004). Lateral sinus thrombosis associated with zoster sine herpete. Am J Otolaryngol, 25: 357-360.
11. CHESKY M, SCALCO R, FAILACE L, READ S, JOBIM LF. (2000). Polymerase chain reaction for diagnosis of aseptic meningitis and encephalitis. Arq Neuropsiquiatr, 58: 836-842.
12. CHOO PW, DONAHUE JG, MANSON JE, PLATT R. (1995). The epidemiology of varicella and its complications. J Infect Dis, 172: 706-712.
13. th cranial nerves. Minerva Me, 68: 4253-4256.
14. CLAVEL M. (1981). Symptomatic herpes zoster and sciatica. A case report. Acta Neurochir (Wien), 58: 259-263.
15. CONNOLLY AM, DODSON WE, PRENSKY AL, RUST RS. (1994). Course and outcome of acute cerebellar ataxia. Ann Neurol, 35: 673-679.
16. CRUZ-VELARDE JA, MUNOZ-BLANCO JL, TRABA A, NEVADO C, ESZPELETA D. (2001). Segmental motor paralysis caused by the varicella-zoster virus. Clinical study and functional prognosis. Rev Neurol, 32: 15-18.
17. DE S, PFLEIDERER AG. (1999). An extreme and unusual variant of Ramsay-Hunt syndrome. J Laryngol Otol, 113: 670-671.
18. DEBIASI RL, KLEINSCHMIDT-DEMASTERS BK, WEINBERG A, TYLER KL. (2002). Use of PCR for the diagnosis of herpesvirus infections of the central nervous system. J Clin Virol, 25: S5-S11.
19. DE SILVA SM, MARK AS, GILDEN DH et al. (1996). Zoster myelitis: improvement with antiviral therapy in two cases. Neurology, 47: 929-931.
20. DEVRIESE PP, MOESKER WH. (1988). The natural history of facial paralysis in herpes zoster. Clin Otolaryngol Allied Sci, 13: 289-298.
21. DONAHUE JG, CHOO PW, MANSON JE, PLATT R. (1995). The incidence of herpes zoster. Arch intern Med, 155: 1605-1609.
22. DRESSLER D, THOMPSON PD, GLEDHILL RF, MARSDEN CD. (1994). The syndrome of painful legs and moving toes. Mov Disord, 9: 13-21.
23. DWORKIN RH, PORTENOY RK. (1994). Proposed classification of herpes zoster pain. Lancet, 343: 1648.
24. nd ed. New York: Elsevier Press. pp. 39-64.
25. ECHEVARRIA JM, CASAS I, MARTINEZ-MARTIN P. (1997). Infections of the central nervous system caused by varicella-zoster virus: a review. Intervirology, 40: 72-84.
26. FABIAN VA, WOOD B, CROWLEY P, KAKULAS BA. (1997). Herpes zoster brachial plexus neuritis. Clin Neuropathol, 16: 61-64.
27. FOX RJ, GALETTA SL, MAHALIGAM R, WELLISH M, FORGHANI B, GILDEN DH. (2001). Acute, chronic, and recurrent varicella zoster virus neuropathy without zoster rash. Neurology, 57: 351-354.
28. FURUTA Y, OHTANI F, MESUDA Y, FUKUDA S, INUYAMA Y. (2000). Early diagnosis of zoster sine herpete and antiviral therapy for the treatment of facial palsy. Neurology, 55: 708-710.
29. GALER BS, ROWBOTHAM MC, PERANDER J, FRIEDMAN E. (1999). Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain, 80: 533-538.
30. GARTY BZ, DINARI G, SARNAT H, COHEN S, NITZAN M. (1985). Tooth exfoliation and osteonecrosis of the maxilla after trigeminal herpes zoster. J Pediar, 106: 71-73.
31. GILDEN DH, DUELAND AN, COHRS R, MARTIN JR, KLEINSCHMIDT-DEMASTERS BK, MAHALINGAM R. (1991). Preherpetic neuralgia. Neurology, 41: 1215-1218.
32. GILDEN DH, BEINLICH BR, RUBINSTEIN EL et al. (1994). Varicella-zoster virus myelitis: an expanding spectrum. Neurology, 44: 1818-1823.
33. GILDEN DH, BENNET JL, KLEINSCHMIDT-DEMASTERS BK, SONG DD, YEE AS, STEINER I. (1998). The value of cerebrospinal fluid antiviral antibody in the diagnosis of neurologic disease produced by varicella zoster virus. J Neurol Sci, 159: 140-144.
34. GILDEN DH, KEINSCHMIDT-DEMASTERS BK, LAGUARDIA JJ, MAHALINGUAM R, COHRS RJ. (2000). Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med, 342: 635-645.
35. GILDEN D. (2004). Varicella Zoster Virus and Central Nervous System Syndromes. Herpes, 11: 89A-94A.
36. GNANN JW, WHITLEY RJ. (2002). Herpes Zoster. N Engl J Med, 347: 340-346.
37. GROSS G. (1997). Zoster: The manifestations forms in the skin, complications and therapy. Dtsch Med Wochenschr, 122: 132-139.
38. GROSS G, SCHÖFFER H, WASSILEW S et al. (2003). Herpes zoster guidelines of the German Dermatology Society (DDG). J Clin Virol, 26: 277-289.
39. GUESS HA, BROUGHTON DD, MELTON LJ III. KURLAND LT. (1985). Epidemiology of herpes zoster in children and adolescents: a population-based study. Pediatrics, 76: 512-517.
40. GUESS HA. (1986). Population-based studies of varicella complications. Pediatrics, 78: 723-727.
41. HAANPÄÄ M, DASTIDAR P, WEINBERG A et al. (1998). CSF and MRI findings in patients with acute herpes zoster. Neurology, 51: 1405-1411.
42. HALL S, CARLIN L, ROACH ES, MCLEAN WT. (1983). Herpes zoster and central retinal artery occlusion. Ann Neurol, 13: 217-218.
43. HART MN, EARLE KM. (1975). Haemorrhagic and perivenous encephalitis: a clinical-pathological review of 38 cases. J Neurol Neurosurg Psychiatry, 38: 585-591.
44. HILT DC, BUCHHOLZ D, KRUMHOLZ A, WEISS H, WOLINSKY JS. (1983). Herpes zoster ophtalmicus and delayed controlateral hemiparesis caused by cerebral angiitis: diagnosis and management approaches. Ann Neurol, 14: 543-553.
45. HIRAGA A, NAGUMO K, SAKAKIBARA R, KOJIMA S, FUJINAWA M, HASHIMOTO T. (2003). Loss of urinary voiding sensation due to herpes zoster. Neurourol Urodyn, 22: 335-337.
46. HOPE-SIMPSON RE. (1975). Postherpetic neuralgia. J R Coll Gen Pract, 25: 571-575.
47. HOPE-SIMPSON RE. (1965). The nature of herpes zoster: a long-term study and a new hypothesis. Proc R Soc Med, 58: 9-20.
48. HUFF JC, BEAN B, BALFOUR HH. (1988). Therapy of herpes zoster with oral acyclovir. Am J Med, 85(Suppl 2A): 84-89.
49. IKEDA K, DEGUCHI K, TOUGE T et al. (2004). Painful legs and moving toes syndrome associated with herpes zoster myelitis. J Neurol Sci, 219: 147-150.
50. JAIN R, DEVEIKIS J, HICKENBOTTOM S, MUCKERJI SK. (2003). Varicella-zoster vasculitis presenting with intracranial hemorrhage. AJNR Am J Neuroradiol, 24: 971-974.
51. JOHNSON RW. DWORKIN RH. (2003). Treatment of herpes zoster and postherpetic neuralgia. Br Med J, 326: 748-750.
52. JONSSON L, TIEN R, ENGSTRÖM M et al. (1995). Gd-DPTA enhanced MRI in Bell's palsy and herpes zoster oticus: an overview and implications for future studies. Acta Otolaryngol, 115: 577-584.
53. KAWASAKI A, BORRUAT FX. (2003). An unusual presentation of herpes zoster ophtalmicus: orbital myositis preceeding vesicular eruption. Am J Ophthalmol, 136: 574-575.
54. KEANE JR. (1975). Delayed trochlear nerve palsy in a case of zoster oticus. Arch Ophtalmol, 93: 382-383.
55. KLEINSCHMIDT-DEMASTERS BK, AMLIE-LEFOND C, GILDEN DH. (1996). The patterns of varicella zoster virus encephalitis. Hum Pathol, 27: 927-938.
56. KNEITZ RH, SCHUBERT J, TOLLMANN F, ZENS W, HEDMAN K, WEISSBRICH B. (2004). A new method for determination of varicella-zoster virus Immunoglobulin G avidity in serum and cerebrospinal fluid. BMC Infect Dis, 4: 33.
57. Koc Y, MILLER KB, SCHEINKEIN DP et al. (2000). Varicella-zoster virus infections following allogenic bone marrow transplantation: frequency, risk factors and clinical outcome. Biol Blood Marrow Transplant, 6: 44-49.
58. KOST RG, STRAUSS SE. (1996). Postherpetic neuralgia - pathogenesis, treatment and prevention. N Engl J Med, 335: 32-42.
59. KOTANI N, KUSHIKATA T, HASHIMOTO H et al. (2000). Intrathecal methylprednisolone for intractable postherpectic neuralgia. N Engl J Med, 343: 1514-1519.
60. KRASNIANSKI M, SIEVERT M, BAU V, ZIERZ S. (2004). External ophtalmoplegia due to ocular myositis in a patient with ophthalmic herpes zoster. Neuromuscul Disord, 14: 438-441.
61. KUBEYINJE EP. (1995). Severity of varicella infection in Saudis with diabetes mellitus: a possible role of acyclovir in treatment. East Afr Med J, 72: 739-741.
62. LAHAT E, LESHEM M, BARZILAI A. (1998). Pseudotumor cerebri complicating varicella in a child. Acta Paediatr, 87: 1310-1311.
63. LAPRESLE J, FAUX N. (1981). Unilateral involvement of IX, X, XI and XII in cervival zoster. Cranial nerve contribution to vascular pathology. J Neurol Sci, 52: 351-357.
64. LÉGER J-M, VIALA K. (2005). Brucellose, leptospirose, Herpes virus, virus varicelle-zona (VZV), cytomégalovirus (CMV), mononucléose infectieuse (Epstein-Barr virus), diphté rie. In : Neuropathies périphériques, polyneuropahies et mononeuropathies multiples, Bouche P, Léger J-M, Vallat J-M, Ed. « Traité de neurologie », vol I, pp. 203-211.
65. LEFÈVRE JP, GIL R, MEDEJEL A, POUGET-ABADIE JF. (1974). Aspects inhabituels du zona : les paralysies zostériennes. J Med Poitiers, 5: 81-83.
66. LEWIS GW. (1958). Zoster sine herpete. Br Med J, 34: 418-421.
67. MAHALINGAM R, WELLISH M, WOLF W et al. (1990). Latent varicella-zoster virus DNA in human trigeminal and thoracic ganglia. N Engl J Med, 323: 627-631.
68. MARSH RJ, DULLEY B, KELLEY V. (1977). External ocular motor palsies in ophtalmic zoster: a review. Br J Ophthalmol, 61: 677-682.
69. MELANSON M, CHALK C, GEORGEVICH L et al. (1996). Varicella-zoster virus DNA in CSF and arteries in delayed controlateral hemiplegia: evidence for viral invasion of cerebral arteries. Neurology, 47: 569-570.
70. MILLICHAP JJ, FREEMAN JL. (2005). Zoster-associated intracranial hypertension. Pediatr Neurol, 32: 211-212.
71. MIYAZAKI Y, TAJIMA Y, SUDO K, MATSUMOTO A, KIKUCHI S, TASHIRO K. (2002). A case of Ramsay Hunt syndrome initiated with hoarseness and dysphagia: consideration on spreading mechanisms of cranial neuropathy. Rinsho Shinkeigaku, 42: 855-858.
72. MONDELLI M, SCARPINI C, MALANDRINI A, ROMANO C. (1997). Painful neuropathy after diffuse herpes zoster. Muscle Nerve, 20: 229-231.
73. MURAKAMI S, HATO N, HORIUCHI J et al. (1997). Treatment of Ramsay Hunt syndrome with acyclovir-prednisone: significance of early diagnosis and treatment. Ann Neurol, 41: 353-357.
74. NAU R, LANTSCH M, STIEFEL M, POLAK T, REIBER H. (1998). Varicella zoster virus-associated focal vasculitis without herpes zoster: recovery after treatment with acyclovir. Neurology, 51: 914-915.
75. ORDOÑEZ G, PINEDA B, GARCIA-NAVARRETE R, SOTELO J. (2004). Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosing. Arch Neurol, 61: 529-532.
76. PERVEZ H, POTTI A, MEHDI SA. (2002). Concomittant bilateral herpes zoster ophtalmicus. Lancet Infect Dis, 2: 699.
77. PLESS ML, MALIK SI. (2003). Relapsing-remitting corticosteroid-sensitive, varicella zoster virus optic neuritis. Pediatr Neurol, 29: 422-424.
78. PURVIN V, HRISOMALOS N, DUNN D. (1988). Varicella optic neuritis. Neurology, 38: 501-503.
79. POGRET MA, MILLER CE. (2003). A case of maxillary necrosis. J Oral Maxillofac Surg, 61: 489-493.
80. PUCHHAMMER-STOCKL E. (1991). Detection of varicella-zoster virus DNA by polymerase chain reaction in the cerebrospinal fluid of patients suffering from neurological complications associated with chickenpox or herpes zoster. J Clin Microbiol, 29: 1513-1516.
81. RAMOS F, MONFORTE C, LUENGO A. (1999). Acute sensory neuropathy associated with a varicella-zoster infection. Rev Neurol, 28: 1067-1069.
82. ROBILLARD RB, HILSINGER RL, ADOUR KK. (1986). Ramsay Hunt facial paralysis: clinical analyses of 185 patients. Otolaryngol Head Neck Surg, 95: 292-297.
83. SCHMADER K, STUDENSKI S, MACMILLAN J, GRUFFERMAN S, COHEN HJ. (1990). Are stressful life events risk factors for herpes zoster? J Am Geriatr Soc, 38: 1188-1194.
84. SCHULZ P, ARBUSOW V, STRUPP M, DIETERICH M, SAUTIER W, BRANDT T. (1999). Sympathetic controlateral vestibulopathy after unilateral zoster oticus. J Neurol Neurosurg Psychiatry, 66: 672-676.
85. STOWASSER M, CAMERON J, OLIVER WA. (1990). Diaphragmatic paralysis following cervical herpes zoster. Med J Aust, 153: 555-556.
86. SWEENEY CJ, GILDEN DH. (2001). Ramsay Hunt syndrome. J Neurol Neurosurg Psychiatry, 71: 149-154.
87. SYAL R, TYAGI I, GOYAL A. (2004). Bilateral Ramsay-Hunt syndrome in a diabetic patient. BMC Ear Nose Throat Disord, 4: 3.
88. THOMAS JE, HOWARD FM. (1972). Segmental zoster paresis - a disease profile. Neurology, 22: 459-466.
89. TAKO J, RADO JP. (1965). Zoster meningoencephalitis in a steroid-treated patient. Arch Neurol, 12: 610-612.
90. WENDLING D, LANGLOIS S, LOHSE A, TOUSSIROD E, MICHEL F. (2004). Herpes zoster sciatica with paresis preceding the skin lesions. Three case-reports. Joint Bone Spine, 71: 588-591.
91. WHITLEY RJ, WEISS H, GNANN JW et al. (1996). Acyclovir with and without prednisone for the treatment of herpes zoster: a randomised, placebo-controlled trial. Ann Intern Med, 125: 376-383.
92. WOOD MJ, JOHNSON RW, MCKENDRICK W, TAYLOR J, MANDAL BK, CROOKS J. (1994). A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. N Eng J Med, 330: 896-900.
93. WOOD MJ, KAY R, DWORKIN RH, SOONG S-J, WHITLEY RJ. (1996). Oral acyclovir therapy accelerates pain resolution in patients with herpes zoster: a meta-analysis of placebo-controlled trials. Clin Infect Dis, 22: 341-347.
94. WOOD MJ, SHUKLA S, FIDDIAN AP, CROOKS RJ. (1998). Treatment of acute herpes zoster: effect of early (<48h) versus late (48-72h) therapy with acyclovir and valaciclovir on prolonged pain. J Infect Dis, 178: S81-S84.
95. XANTHOPOULOS J, NOUSSIOS G, PAPAIOANNIDES D, EXARCHAKOS G, ASSIMAKOPOULOS D. (2002). Ramsay Hunt syndrome presenting as a cranial polyneuropathy. Acta Otorhinolaryngol Belg, 56: 319-323.
96. YOSHIKAWA T, SUZUKI K, SUGA S et al. (2000). Immune response to gangliosides in a case of Guillain-Barré syndrome after varicella. Arch Dis Child, 83: 172-173.